SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-160873
Filing Date
2009-07-31
Accepted
2009-07-31 16:39:46
Documents
4
Period of Report
2009-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15809
2 PRESS RELEASE DATED JULY 31, 2009 dex991.htm EX-99.1 70411
3 GRAPHIC g17725ex99_1pg001a.jpg GRAPHIC 20545
4 GRAPHIC g17725footer.jpg GRAPHIC 21146
  Complete submission text file 0001193125-09-160873.txt   145666
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 09977791
SIC: 2834 Pharmaceutical Preparations